Your browser doesn't support javascript.
loading
[Cholesterol associated to low density lipoproteins (LDL) and vascular risk reduction. Proprotein convertase subtilisin/kexin type 9 (PCSK9): A new therapeutic target]. / Colesterol ligado a lipoproteínas de baja densidad (LDL) y reducción del riesgo vascular. Proproteína convertasa subtilisina / kexina tipo 9 (PCSK9): una nueva diana terapéutica.
Guijarro, Carlos; Ruilope, Luis Miguel.
Affiliation
  • Guijarro C; Unidad de Medicina Interna, Consulta de Riesgo Vascular, Hospital Universitario Fundación Alcorcón, Universidad Rey Juan Carlos, Madrid, España. Electronic address: cguijarro@fhalcorcon.es.
  • Ruilope LM; Instituto de Investigación, Unidad de Hipertensión, Hospital Universitario 12 de Octubre, Madrid, España.
Med Clin (Barc) ; 145(2): 67-9, 2015 Jul 20.
Article in Es | MEDLINE | ID: mdl-26004275

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Serine Endopeptidases / Proprotein Convertases / Hypercholesterolemia / Hyperlipoproteinemias / Lipoproteins, LDL / Antibodies, Monoclonal / Hypolipidemic Agents Type of study: Etiology_studies / Risk_factors_studies Limits: Humans Language: Es Journal: Med Clin (Barc) Year: 2015 Document type: Article Country of publication: Spain

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Serine Endopeptidases / Proprotein Convertases / Hypercholesterolemia / Hyperlipoproteinemias / Lipoproteins, LDL / Antibodies, Monoclonal / Hypolipidemic Agents Type of study: Etiology_studies / Risk_factors_studies Limits: Humans Language: Es Journal: Med Clin (Barc) Year: 2015 Document type: Article Country of publication: Spain